Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

January 01, 1983; Volume 23,Issue 1
  • You have access
    High-affinity, divalent ion-specific binding of 3H-ATP to homogenate derived from rabbit urinary bladder. Comparison with divalent-ion ATPase activity.
    R M Levin, R Jacoby and A J Wein
    Molecular Pharmacology January 1983, 23 (1) 1-7;
  • You have access
    The influence of antibiotics on agonist occupation and functional states of the nicotinic acetylcholine receptor.
    R D Brown and P Taylor
    Molecular Pharmacology January 1983, 23 (1) 8-16;
  • You have access
    Affinity, efficacy, and stereoselectivity of oxotremorine analogues for muscarinic receptors in the isolated guinea pig ileum.
    B Ringdahl and D J Jenden
    Molecular Pharmacology January 1983, 23 (1) 17-25;
  • You have access
    Opiate regulation of adenosine 3':5'-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Relationship between receptor occupancy and effect.
    P Y Law, D S Hom and H H Loh
    Molecular Pharmacology January 1983, 23 (1) 26-35;
  • You have access
    Comparison of dynorphin-selective Kappa receptors in mouse vas deferens and guinea pig ileum. Spare receptor fraction as a determinant of potency.
    B M Cox and C Chavkin
    Molecular Pharmacology January 1983, 23 (1) 36-43;
  • You have access
    Gonadotropin-releasing hormone binding to rat anterior pituitary membrane homogenates. Comparison of antagonists and agonists using radiolabeled antagonist and agonist.
    M H Perrin, Y Haas, J E Rivier and W W Vale
    Molecular Pharmacology January 1983, 23 (1) 44-51;
  • You have access
    Group-selective reagent modification of the benzodiazepine-gamma-aminobutyric acid receptor-ionophore complex reveals that low-affinity gamma-aminobutyric acid receptors stimulate benzodiazepine binding.
    T P Burch, R Thyagarajan and M K Ticku
    Molecular Pharmacology January 1983, 23 (1) 52-59;
  • You have access
    Temperature dependence of the binding of [3H]mepyramine and related compounds to the histamine H1 receptor.
    R M Wallace and J M Young
    Molecular Pharmacology January 1983, 23 (1) 60-66;
  • You have access
    Trifluoperazine and chlorpromazine antagonize alpha 1- but not alpha2- adrenergic effects.
    J Huerta-Bahena, R Villalobos-Molina and J A García-Sáinz
    Molecular Pharmacology January 1983, 23 (1) 67-70;
  • You have access
    Effects of antimycin A on receptor-activated calcium mobilization and phosphoinositide metabolism in rat parotid gland.
    J Poggioli, S J Weiss, J S McKinney and J W Putney
    Molecular Pharmacology January 1983, 23 (1) 71-77;
  • You have access
    Effect of calmodulin and calmodulin antagonists on the Ca2+ uptake by the intracellular Ca2+-accumulating system of guinea pig peritoneal macrophages treated with saponin.
    M Hirata, E Suematsu and T Koga
    Molecular Pharmacology January 1983, 23 (1) 78-85;
  • You have access
    Changes in synaptic membrane order associated with chronic ethanol treatment in mice.
    R C Lyon and D B Goldstein
    Molecular Pharmacology January 1983, 23 (1) 86-91;
  • You have access
    Anion transport inhibitors as suppressors of Plasmodium falciparum growth in in vitro cultures.
    Z I Cabantchik, S Kutner, M Krugliak and H Ginsburg
    Molecular Pharmacology January 1983, 23 (1) 92-99;
  • You have access
    The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
    C T Noguchi, S Ackerman, J DiMaio, P W Schiller and A N Schechter
    Molecular Pharmacology January 1983, 23 (1) 100-103;
  • You have access
    Steady-state kinetics of bovine striatal tyrosine hydroxylase.
    W P Bullard and T L Capson
    Molecular Pharmacology January 1983, 23 (1) 104-111;
  • You have access
    Metabolic clearance rate of dopamine beta-hydroxylase in the rat.
    J M Stolk, J H Hurst, R B Guchhait, G Vantini, G P Lefort and B C Nisula
    Molecular Pharmacology January 1983, 23 (1) 112-120;
  • You have access
    Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.
    S Burstein, S A Hunter and K Ozman
    Molecular Pharmacology January 1983, 23 (1) 121-126;
  • You have access
    Conformations of fortimicins and three-dimensional structure-activity relationship in the aminoglycoside antibiotics.
    N Hirayama, K Shirahata, Y Ohashi and Y Sasada
    Molecular Pharmacology January 1983, 23 (1) 127-132;
  • You have access
    Correlation of structure and activity in ansamycins. Molecular structure of sodium rifamycin SV.
    S K Arora
    Molecular Pharmacology January 1983, 23 (1) 133-140;
  • You have access
    3-O-methyl-D-glucose uptake in isolated rat hepatocytes. Effects of dexamethasone.
    Z Madar and P Felig
    Molecular Pharmacology January 1983, 23 (1) 141-145;
  • You have access
    Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
    W P Gati, E E Knaus and L I Wiebe
    Molecular Pharmacology January 1983, 23 (1) 146-152;
  • You have access
    Transport of uridine and 6-azauridine in human lymphoblastoid cells. Specificity for the uncharged 6-azauridine molecule.
    J A Belt and A D Welch
    Molecular Pharmacology January 1983, 23 (1) 153-158;
  • You have access
    Human deoxycytidylate deaminase. Substrate and regulator specificities and their chemotherapeutic implications.
    W R Mancini and Y C Cheng
    Molecular Pharmacology January 1983, 23 (1) 159-164;
  • You have access
    2'-deoxycoformycin toxicity in murine spleen lymphocytes.
    M F Earle and R I Glazer
    Molecular Pharmacology January 1983, 23 (1) 165-170;
  • You have access
    Effects of 5-fluoro-2'-deoxyuridine on DNA metabolism in HeLa cells.
    Y C Cheng and K Nakayama
    Molecular Pharmacology January 1983, 23 (1) 171-174;
  • You have access
    Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    J Balzarini and E De Clercq
    Molecular Pharmacology January 1983, 23 (1) 175-181;
  • You have access
    Mechanistic studies of a novel antitumor drug, alpha-1,3,5-triglycidyl-s-triazinetrione. Antitumor and cytotoxic effects.
    F Y WU and J B Le Pecq
    Molecular Pharmacology January 1983, 23 (1) 182-189;
  • You have access
    Relationship of cellular folate cofactor pools to the activity of 5-fluorouracil.
    M B Yin, S F Zakrzewski and M T Hakala
    Molecular Pharmacology January 1983, 23 (1) 190-197;
  • You have access
    Benz[a]anthracene and 3-methylcholanthrene induction of cytochrome P-450 in C3H/10T1/2 mouse fibroblasts. Modulating role of cytotoxic 3-methylcholanthrene metabolites.
    D Ho, K Gill and W E Fahl
    Molecular Pharmacology January 1983, 23 (1) 198-205;
  • You have access
    Differential destruction of cytochrome P-450-dependent monooxygenases in rat and mouse kidney following hexachloro-1:3-butadiene administration.
    C R Wolf, J B Hook and E A Lock
    Molecular Pharmacology January 1983, 23 (1) 206-212;
  • You have access
    Quantitative structure-activity study on the mechanism of inhibition of microsomal p-hydroxylation of aniline by alcohols. Role of steric factors.
    A Sabljić and M Protić-Sabljić
    Molecular Pharmacology January 1983, 23 (1) 213-218;
  • You have access
    Studies of the mechanism of metabolism of thioacetamide s-oxide by rat liver microsomes.
    M C Dyroff and R A Neal
    Molecular Pharmacology January 1983, 23 (1) 219-227;
  • You have access
    Alpha 2-adrenergic receptor in intestinal epithelial cells. Identification by [3H]yohimbine and failure to inhibit cyclic AMP accumulation.
    T Nakaki, T Nakadate, S Yamamoto and R Kato
    Molecular Pharmacology January 1983, 23 (1) 228-234;
  • You have access
    Effects of phenobarbital and 3-methylcholanthrene pretreatments on monooxygenase activities and proportions of isolated rat hepatocyte subpopulations.
    K Tonda, T Hasegawa and M Hirata
    Molecular Pharmacology January 1983, 23 (1) 235-243;
  • You have access
    Effect of inducers and aging on rabbit liver microsomal drug-metabolizing enzymes.
    J Y Chiang, A G DiLella and A W Steggles
    Molecular Pharmacology January 1983, 23 (1) 244-251;
  • You have access
    Immunochemical evidence for two 3-methylcholanthrene-inducible forms of cytochrome P-448 in rat liver microsomes using a double-antibody radioimmunoassay procedure.
    M I Luster, L D Lawson, P Linko and J A Goldstein
    Molecular Pharmacology January 1983, 23 (1) 252-257;
  • You have access
    Purification and characterization of three forms of microsomal cytochrome P-450 in liver from 3-methylcholanthrene-treated guinea pigs.
    T Abe and M Watanabe
    Molecular Pharmacology January 1983, 23 (1) 258-264;
  • You have access
    Xylene induces a cytochrome P-450 isozyme in rat liver similar to the major isozyme induced by phenobarbital.
    R Toftgård, J Halpert and J A Gustafsson
    Molecular Pharmacology January 1983, 23 (1) 265-271;
Back to top
PreviousNext

In this issue

Molecular Pharmacology
Vol. 23, Issue 1
1 Jan 1983
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics